0.012674
0.000000
0.000000
0.000000
0.012674
0.000000
0.000000
0.000000
0.012674
0.00000
0.00000
0.00000
Gursky, O.
Badger, J.
Li, Y.
Caspar, D.L.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
24
90.00
90.00
90.00
78.900
78.900
78.900
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H4 Cl2
98.959
1,2-DICHLOROETHANE
ETHYLENE DICHLORIDE
non-polymer
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
Na 1
22.990
SODIUM ION
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biophys.J.
BIOJAU
0030
0006-3495
63
1210
1220
1477273
Conformational changes in cubic insulin crystals in the pH range 7-11.
1992
US
Biophys.J.
BIOJAU
0030
0006-3495
61
604
Monovalent Cation Binding in Cubic Insulin Crystals
1992
US
Biophys.J.
BIOJAU
0030
0006-3495
61
816
Flexibility in Crystalline Insulins
1992
DK
Acta Crystallogr.,Sect.B
ASBSDK
0622
0108-7681
47
127
Structure of the Pig Insulin Dimer in the Cubic Crystal
1991
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
88
622
Water Structure in Cubic Insulin Crystals
1991
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
125
387
Zinc-Free Cubic Pig Insulin: Crystallization and Structure Determination
1978
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
x-ray
1
1.0
2339.645
INSULIN A CHAIN (PH 11)
1
man
polymer
3403.927
INSULIN B CHAIN (PH 11)
1
man
polymer
22.990
SODIUM ION
1
syn
non-polymer
98.959
1,2-DICHLOROETHANE
1
syn
non-polymer
18.015
water
60
nat
water
no
no
GIVEQCCASVCSLYQLENYCN
GIVEQCCASVCSLYQLENYCN
A
polypeptide(L)
no
no
FVNQHLCGSHLVEALYLVCGERGFFYTPKA
FVNQHLCGSHLVEALYLVCGERGFFYTPKA
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
cattle
Bos
sample
9913
Bos taurus
cattle
Bos
sample
9913
Bos taurus
3.56
65.47
pdbx_database_status
struct_conf
struct_conf_type
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1993-01-15
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
0.1M SODIUM SALT SOLUTION AT PH 7
0.1M SODIUM SALT SOLUTION AT PH 9
0.1M SODIUM SALT SOLUTION AT PH 10
SHEET
THERE IS A SHEET COMPRISING TWO ANTIPARALLEL STRANDS
PHE B 24 - TYR B 26 FROM TWO DIMER-FORMING INSULIN
MOLECULES.
Y
BNL
1992-10-30
REL
REL
NA
SODIUM ION
DCE
1,2-DICHLOROETHANE
HOH
water
THE 1,2-DICHLOROETHANE IS BOUND IS CIS CONFORMATION IN A
SYMMETRIC POSITION ACROSS THE CRYSTALLOGRAPHIC TWO-FOLD
AXIS BETWEEN THE TWO INSULIN DIMER-FORMING MOLECULES.
NA
88
3
NA
NA
88
A
DCE
200
4
DCE
DCE
200
B
HOH
1
5
HOH
HOH
89
A
HOH
10
5
HOH
HOH
90
A
HOH
12
5
HOH
HOH
91
A
HOH
13
5
HOH
HOH
92
A
HOH
15
5
HOH
HOH
93
A
HOH
18
5
HOH
HOH
94
A
HOH
21
5
HOH
HOH
95
A
HOH
23
5
HOH
HOH
96
A
HOH
24
5
HOH
HOH
97
A
HOH
26
5
HOH
HOH
98
A
HOH
30
5
HOH
HOH
99
A
HOH
33
5
HOH
HOH
100
A
HOH
35
5
HOH
HOH
101
A
HOH
39
5
HOH
HOH
102
A
HOH
41
5
HOH
HOH
103
A
HOH
42
5
HOH
HOH
104
A
HOH
43
5
HOH
HOH
105
A
HOH
44
5
HOH
HOH
106
A
HOH
45
5
HOH
HOH
107
A
HOH
47
5
HOH
HOH
108
A
HOH
53
5
HOH
HOH
109
A
HOH
54
5
HOH
HOH
110
A
HOH
56
5
HOH
HOH
111
A
HOH
59
5
HOH
HOH
112
A
HOH
60
5
HOH
HOH
113
A
HOH
2
5
HOH
HOH
201
B
HOH
3
5
HOH
HOH
202
B
HOH
4
5
HOH
HOH
203
B
HOH
5
5
HOH
HOH
204
B
HOH
6
5
HOH
HOH
205
B
HOH
7
5
HOH
HOH
206
B
HOH
8
5
HOH
HOH
207
B
HOH
9
5
HOH
HOH
208
B
HOH
11
5
HOH
HOH
209
B
HOH
14
5
HOH
HOH
210
B
HOH
16
5
HOH
HOH
211
B
HOH
17
5
HOH
HOH
212
B
HOH
19
5
HOH
HOH
213
B
HOH
20
5
HOH
HOH
214
B
HOH
22
5
HOH
HOH
215
B
HOH
25
5
HOH
HOH
216
B
HOH
27
5
HOH
HOH
217
B
HOH
28
5
HOH
HOH
218
B
HOH
29
5
HOH
HOH
219
B
HOH
31
5
HOH
HOH
220
B
HOH
32
5
HOH
HOH
221
B
HOH
34
5
HOH
HOH
222
B
HOH
36
5
HOH
HOH
223
B
HOH
37
5
HOH
HOH
224
B
HOH
38
5
HOH
HOH
225
B
HOH
40
5
HOH
HOH
226
B
HOH
46
5
HOH
HOH
227
B
HOH
48
5
HOH
HOH
228
B
HOH
49
5
HOH
HOH
229
B
HOH
50
5
HOH
HOH
230
B
HOH
51
5
HOH
HOH
231
B
HOH
52
5
HOH
HOH
232
B
HOH
55
5
HOH
HOH
233
B
HOH
57
5
HOH
HOH
234
B
HOH
58
5
HOH
HOH
235
B
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
ALA
8
n
8
ALA
8
A
SER
9
n
9
SER
9
A
VAL
10
n
10
VAL
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
PRO
28
n
28
PRO
28
B
LYS
29
n
29
LYS
29
B
ALA
30
n
30
ALA
30
B
author_and_software_defined_assembly
PISA
2
dimeric
software_defined_assembly
PISA
4
tetrameric
software_defined_assembly
PISA
4
tetrameric
software_defined_assembly
PISA
4
tetrameric
1640
-20
3270
4900
-72
5350
3170
-66
7080
4240
-54
5570
A
HOH
94
E
O
HOH
1_555
A
NA
88
C
NA
NA
1_555
A
GLN
5
A
O
GLN
5
1_555
96.7
A
HOH
94
E
O
HOH
1_555
A
NA
88
C
NA
NA
1_555
A
VAL
10
A
O
VAL
10
1_555
110.9
A
GLN
5
A
O
GLN
5
1_555
A
NA
88
C
NA
NA
1_555
A
VAL
10
A
O
VAL
10
1_555
83.3
A
HOH
94
E
O
HOH
1_555
A
NA
88
C
NA
NA
1_555
A
HOH
96
E
O
HOH
1_555
83.4
A
GLN
5
A
O
GLN
5
1_555
A
NA
88
C
NA
NA
1_555
A
HOH
96
E
O
HOH
1_555
165.2
A
VAL
10
A
O
VAL
10
1_555
A
NA
88
C
NA
NA
1_555
A
HOH
96
E
O
HOH
1_555
82.8
A
HOH
94
E
O
HOH
1_555
A
NA
88
C
NA
NA
1_555
A
SER
9
A
OG
SER
9
1_555
119.6
A
GLN
5
A
O
GLN
5
1_555
A
NA
88
C
NA
NA
1_555
A
SER
9
A
OG
SER
9
1_555
77.6
A
VAL
10
A
O
VAL
10
1_555
A
NA
88
C
NA
NA
1_555
A
SER
9
A
OG
SER
9
1_555
127.5
A
HOH
96
E
O
HOH
1_555
A
NA
88
C
NA
NA
1_555
A
SER
9
A
OG
SER
9
1_555
115.3
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
16_565
x,-y+1,-z+1/2
crystal symmetry operation
0.0000000000
78.9000000000
39.4500000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
15_556
-x+1/2,y,-z+1
crystal symmetry operation
39.4500000000
0.0000000000
78.9000000000
0.0000000000
0.0000000000
1.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
5_555
z,x,y
crystal symmetry operation
0.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
20_556
-z+1/2,x,-y+1
crystal symmetry operation
39.4500000000
0.0000000000
78.9000000000
1
B
HOH
230
F
HOH
1
B
CG
LYS
29
B
CG
LYS
29
1
Y
1
B
CD
LYS
29
B
CD
LYS
29
1
Y
1
B
CE
LYS
29
B
CE
LYS
29
1
Y
1
B
NZ
LYS
29
B
NZ
LYS
29
1
Y
1
-9.40
1.20
123.30
113.90
A
A
A
OE1
CD
OE2
GLU
GLU
GLU
4
4
4
N
1
4.29
0.60
121.00
125.29
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
A
A
A
N
1
-4.32
0.60
121.00
116.68
A
A
A
CB
CG
CD1
TYR
TYR
TYR
14
14
14
A
A
A
N
1
22.73
1.80
110.60
133.33
A
A
A
N
CA
CB
ASN
ASN
ASN
18
18
18
B
N
1
7.27
1.10
114.20
121.47
A
A
A
CA
CB
SG
CYS
CYS
CYS
20
20
20
N
1
-13.20
2.00
118.30
105.10
B
B
B
CG
CD
OE2
GLU
GLU
GLU
13
13
13
N
1
25.22
2.00
110.40
135.62
B
B
B
CB
CA
C
GLU
GLU
GLU
21
21
21
B
N
1
-13.23
1.80
110.60
97.37
B
B
B
N
CA
CB
GLU
GLU
GLU
21
21
21
B
N
1
32.80
2.20
113.40
146.20
B
B
B
CA
CB
CG
GLU
GLU
GLU
21
21
21
A
A
N
1
-21.63
2.20
113.40
91.77
B
B
B
CA
CB
CG
GLU
GLU
GLU
21
21
21
B
B
N
1
14.83
1.80
110.60
125.43
B
B
B
N
CA
CB
ARG
ARG
ARG
22
22
22
B
N
1
-6.64
0.50
120.30
113.66
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
22
22
22
B
B
B
N
1
-17.54
2.00
110.40
92.86
B
B
B
CB
CA
C
PHE
PHE
PHE
25
25
25
B
N
1
B
LYS
29
-64.12
93.70
IN 1BPH AND 1CPH, THE SIDE CHAIN OF GLU A 4 CAN ADOPT TWO
ALTERNATIVE POSITIONS WHICH OVERLAP. THEIR RELATIVE WEIGHT
AND THE ATOMIC POSITIONS OF THE SECOND CONFORMER ARE NOT
ACCURATELY DETERMINED.
IN 1APH, 1BPH, AND 1DPH, THE SIDE CHAIN OF GLU B 21 IS
DISORDERED. IT HAS BEEN MODELED AS SUPERPOSITION OF TWO
CONFORMATIONS BUT ATOMIC POSITIONS FOR THESE CONFORMATIONS
ARE PROBABLY NOT VERY ACCURATE.
THE SIDE CHAIN OF LYS B 29 IS POORLY DEFINED IN THE
ELECTRON DENSITY MAPS. IN 1APH AND 1CPH, IT IS INCLUDED
WITH PARTIAL OCCUPANCY. IN 1BPH AND 1DPH, ITS COORDINATES
HAVE BEEN OMITTED FROM THE ENTRY.
THE MAIN AND SIDE CHAIN OF ALA B 30 (C-TERMINAL RESIDUE OF
CHAIN B) CAN ADOPT TWO SEPARATE CONFORMATIONS AND IS
DISORDERED IN EACH OF THESE CONFORMATIONS, WHICH LIMITED
THE ACCURACY OF DETERMINATION OF ATOMIC POSITIONS FOR THE
CONFORMERS OF ALA B 30. IN 1APH AND 1CPH, SINGLE
ALTERNATIVE CONFORMERS ARE PREDOMINANT BUT, DUE TO
DISORDER, THEY ARE ASSIGNED PARTIAL OCCUPANCIES. IN 1BPH
AND 1DPH, BOTH ALTERNATIVE CONFORMERS ARE INCLUDED IN THE
ENTRY.
0.19
1.9
1
1.9
60
504
5
0
439
0.018
refinement
PROLSQ
INSULIN (CUBIC) IN 0.1M SODIUM SALT SOLUTION AT PH11
CONFORMATIONAL CHANGES IN CUBIC INSULIN CRYSTALS IN THE PH RANGE 7-11
1
N
N
2
N
N
3
N
N
4
N
N
5
N
N
5
N
N
A
GLY
1
A
GLY
1
HELX_P
A
VAL
10
A
VAL
10
1
A1
10
A
SER
12
A
SER
12
HELX_P
NOT IDEAL
A
GLU
17
A
GLU
17
5
A2
6
B
SER
9
B
SER
9
HELX_P
B
GLY
20
B
GLY
20
1
B1
12
disulf
1.954
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
1.951
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
1.970
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
metalc
2.318
A
NA
88
C
NA
NA
1_555
A
HOH
94
E
O
HOH
1_555
metalc
2.391
A
NA
88
C
NA
NA
1_555
A
GLN
5
A
O
GLN
5
1_555
metalc
2.330
A
NA
88
C
NA
NA
1_555
A
VAL
10
A
O
VAL
10
1_555
metalc
2.340
A
NA
88
C
NA
NA
1_555
A
HOH
96
E
O
HOH
1_555
metalc
2.914
A
SER
9
A
OG
SER
9
1_555
A
NA
88
C
NA
NA
1_555
HORMONE
HORMONE
INS_BOVIN
UNP
1
85
P01317
INS_BOVIN
UNP
2
25
P01317
85
105
1DPH
1
21
P01317
A
1
1
21
25
54
1DPH
1
30
P01317
B
2
1
30
BINDING SITE FOR RESIDUE NA A 88
Software
7
BINDING SITE FOR RESIDUE DCE B 200
Software
3
A
GLN
5
A
GLN
5
7
1_555
A
SER
9
A
SER
9
7
1_555
A
VAL
10
A
VAL
10
7
1_555
A
HOH
94
E
HOH
7
15_556
A
HOH
94
E
HOH
7
1_555
A
HOH
96
E
HOH
7
1_555
A
HOH
96
E
HOH
7
15_556
B
SER
9
B
SER
9
3
1_555
B
VAL
12
B
VAL
12
3
16_565
B
GLU
13
B
GLU
13
3
16_565
199
I 21 3